Foghorn Therapeutics Stock Forecast

Stock Price Forecast

According to 10 analysts polled by S&P Global, Foghorn Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $11.44. The average 1-year stock price forecast is 183.87% higher than the current stock price, while the lowest is $9.00 (+123.33%) and the highest is $14 (+247.39%).

Price Target: $11.44 (+183.87%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$9.00	$11.44	$12	$14
Change	+123.33%	+183.87%	+197.77%	+247.39%

Analyst Ratings

The average analyst rating for Foghorn Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	9	9	9	9	9	9
Buy	1	1	1	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	10	10	10	10	10	10

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Laura Prendergast Stifel Nicolaus	Stifel Nicolaus	Buy Maintains $12	Buy	Maintains	$12	+197.77%	Jun 1, 2026
Robert Driscoll Wedbush	Wedbush	Buy Reiterates $10	Buy	Reiterates	$10	+148.14%	May 8, 2026
Unknown Analyst Guggenheim No rating	Guggenheim	Buy Maintains $12	Buy	Maintains	$12	+197.77%	May 8, 2026
Andres Y. Maldonado H.C. Wainwright	H.C. Wainwright	Buy Reiterates $13	Buy	Reiterates	$13	+222.58%	May 8, 2026
Yaron Werber TD Cowen	TD Cowen	Buy Maintains n/a	Buy	Maintains	n/a	n/a	May 7, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

25.84M

from 30.91M

-16.40%

from 30.91M

Revenue Next Year

37.42M

from 25.84M

44.81%

from 25.84M

EPS This Year

-0.99

from -1.21

EPS Next Year

-0.93

from -0.99

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	1.32M	19.23M	34.16M	22.60M	30.91M	25.84M
Revenue Growth	206.74%	1,357.77%	77.63%	-33.83%	36.75%	-16.40%
Operating Income	-100.73M	-117.14M	-107.91M	-100.29M	-82.11M	-81.23M
Net Income	-101.32M	-108.88M	-98.43M	-86.62M	-74.28M	-71.96M
EPS	-	-	-	-	-1.21	-0.99
Free Cash Flow	-329.38M	250.45M	-48.87M	-40.30M	-35.23M	-59.83M
No. Analysts	-	-	-	-	-	10

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	40.7M
Avg	25.8M
Low	3.3M

Revenue Growth

Revenue Growth	2026	2027	2028
High	31.7%
Avg	-16.4%
Low	-89.4%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	-0.99
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-